de la Fuente-Nunez is a presidential associate professor at the University of Pennsylvania. Skinner is CEO of the AMR Action Fund. Of all the areas of drug development that artificial intelligence has ...

Some bacteria do not defeat antibiotics by evolving resistance right away—they outlast treatment by slipping into ...

Governments must do more to support the economic case for infectious disease medicines if effective antibiotics are to remain ...

Two newly discovered mechanisms in bacteria have been identified that can contribute to the development of antibiotic resistance. Changing the number of copies of resistance genes in bacteria ...

Antibiotics are medications that treat bacterial infections. They achieve this by killing bacteria or slowing their growth. Some common types of antibiotics include penicillin and macrolides. Medical ...

Painkillers we often trust — ibuprofen and acetaminophen — may be quietly accelerating one of the world’s greatest health crises: antibiotic resistance. Researchers discovered that these drugs not ...

Around 50% of patients develop an infection in the final months, weeks, or days before their deaths. Diagnosing an infection is complex because of the presence of symptoms that are often nonspecific ...

A recent study reveals that antibiotic-resistant typhoid infections accounted for 87% of India's economic burden of Rs 123 ...